Western blotting showed that, compared with sorafenib-sensitive HCC cells, sorafenib-resistant cells with high expression of FNDC5 presented elevated expression of PI3K, increased levels of downstream pAkt, and elevated levels of Nrf2 in the nucleus. This evidence concerns the gene FNDC5 and hepatocellular carcinoma.